🇺🇸 FDA
Patent

US 8283151

Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes

granted A61PA61P31/12

Quick answer

US patent 8283151 (Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P31/12